AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22518377
Drug: at least
RxNorm normalized name: Lovaza 1000 MG (at least 900 MG) Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: at least 10 mm-long implants in augmented bone
Trial: 17509302
Drug: 25 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg/m2 vinorelbine (arm B)
Trial: 12375715
Drug: Suplatast tosilate
RxNorm normalized name: Edoxaban Tosylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suplatast tosilate (100 mg t.i.d. for 28 days)
Trial: 10980831
Drug: Intervention with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention with agents that lower triglycerides and raise HDL
Trial: 2185042
Drug: Timed intercourse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timed intercourse with clomiphene citrate (CC)
Trial: 74317
Drug: Alcohol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol plus pyrithioxine (7 mg/kg)
Trial: 30234616
Drug: Clostridium butyricum
RxNorm normalized name: Clostridium butyricum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clostridium butyricum MIYAIRI 588 (CBM588) 60 mg/d in combination with antidepressants
Trial: 17294999
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg metoclopramide
Trial: 18158814
Drug: 40 mcg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mcg/kg granisetron
Trial: 18158814
Drug: 15 mcg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mcg/kg ondansetron
Trial: 25040766
Drug: 0.25% sodium
RxNorm normalized name: Supred, 0.25% sodium phosphate-10% ophthalmic suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% sodium hypochlorite oral rinse
Trial: 17964576
Drug: Antimuscarinic drug
RxNorm normalized name: ANTIMUSCARINICS/ANTISPASMODICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimuscarinic drug scopolamine (SCOP)
Trial: 17964576
Drug: Antinicotinic drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antinicotinic drug mecamylamine (MECA)
Trial: 16569537
Drug: Temocapril (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temocapril (2 mg/d)
Trial: 11135211
Drug: Doxorubicin 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 40 mg/m(2) and cyclophosphamide 600 mg/m(2) intravenously every 3 weeks (AC)
Trial: 3932509
Drug: Controlled diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled diet supplemented with 2000 kCal and 10 g nitrogen daily (branched chain amino acid enriched formulation)
Trial: 24503174
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (24IU)
Trial: 28372849
Drug: Protein hydrolysate
RxNorm normalized name: Protein hydrolysate
DrugBank: Protein hydrolysate (DB09356)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein hydrolysate drink (8.5 g before breakfast and 8.5 g before dinner)
Trial: 20098520
Drug: Eszopiclone 3
RxNorm normalized name: eszopiclone 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eszopiclone 3 mg
Trial: 24215127
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of ranibizumab (0.5 mg)
Trial: 19756418
Drug: Tobramycin once
RxNorm normalized name: Tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin once daily (treatment B)
Trial: 15837983
Drug: FEC 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEC 100 (fluorouracil 500 mg/m2, cyclophosphamide 500 mg/m2, epirubicin 100 mg/m2)
Trial: 9878641
Drug: Inhaled tobramycin
RxNorm normalized name: tobramycin Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled tobramycin (300 mg, twice daily for four weeks)
Trial: 8924741
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (n=27)
Trial: 7152080
Drug: Diprosalic lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diprosalic lotion (betamethasone dipropionate and salicylic acid)
Trial: 7152080
Drug: Dermovate lotion
RxNorm normalized name: Dermovate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dermovate lotion (clobetasol propionate)
Trial: 27161178
Drug: Dulaglutide 1.5
RxNorm normalized name: dulaglutide 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide 1.5 mg and 0.75 mg
Trial: 27981279
Drug: Intra-articular platelet-rich
RxNorm normalized name: Platelet Rich Plasma
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular platelet-rich plasma (PRP) (3 ml)
Trial: 18242485
Drug: Adenosine infusion
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine infusion (140 microg/kg/min)
Trial: 26173463
Drug: Mandibular implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular implant fixed partial prostheses (IFPP)
Trial: 26173463
Drug: Mandibular implant-supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular implant-supported overdenture (ISOD)
Trial: 25005327
Drug: golimumab 100
RxNorm normalized name: golimumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: golimumab 100 mg + MTX
Trial: 22386826
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg commercial sildenafil (reference)
Trial: 16195581
Drug: Milk fermented
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk fermented with Lactobacillus acidophilus strain L-92 (L-92), 100 ml, containing 5 x 10(10) bacteria, twice a day for 6 weeks
Trial: 9475563
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 microg inhaled at bedtime followed by unblinded salmeterol 50 microg inhaled 12 hours later
Trial: 9475563
Drug: Placebo inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo inhaled at bedtime followed by unblinded salmeterol 50 microg inhaled 12 hours later
Trial: 1082238
Drug: Alternate day
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate day dose of vitamin A in addition to massive therapy
Trial: 27155753
Drug: FP group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP group (100 μg b.i.d.)
Trial: 22258708
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 30 μg HA
Trial: 22258708
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 15 μg HA for elderly
Trial: 3899506
Drug: Oral contraception
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraception
Trial: 17998491
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of strength training and Fibromyalgia Self‐Help Course (ST-FSHC)
Trial: 17998491
Drug: Exercise alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise alone and in combination with education
Trial: 2268533
Drug: Concurrent intrathecal
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent intrathecal methotrexate therapy
Trial: 2268533
Drug: No concurrent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No concurrent intrathecal methotrexate therapy
Trial: 26228322
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of cefuroxime sodium and metronidazole (Group A)
Trial: 26228322
Drug: Repeated dose
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated dose of cefuroxime sodium and metronidazole (Group B)
Trial: 22619107
Drug: Sustained virological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained virological response (SVR) after PEG‐IFNα2a/RBV or PEG‐IFNα2b/RBV treatment
Trial: 22619107
Drug: Treatment failure
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment failure (non-SVR)
Trial: 17519217
Drug: Narrowband-UV-B (NB‐UVB)
RxNorm normalized name: Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrowband-UV-B (NB‐UVB) therapy
Trial: 11513170
Drug: Eradication treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication treatment
Trial: 9685916
Drug: Soft gelatin
RxNorm normalized name: Norvir Soft Gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft gelatin capsule containing PEG 400 suspension of gliclazide
Trial: 9685916
Drug: Diamicron (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diamicron (conventional tablet)
Trial: 2985658
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg tid increased to 100 mg tid)
Trial: 2985658
Drug: Methyldopa (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (250 mg to 500 mg bid and 1,000 mg bid)
Trial: 30882578
Drug: Postoperative Radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative Radiation Therapy (PR group) with 150 mg/m/wk intra-arterial cisplatin for 4 weeks followed by radiotherapy
Trial: 30882578
Drug: Definitive Radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Definitive Radiation Therapy (DR group) with 150 mg/m/wk intra-arterial cisplatin for 4 weeks followed by definitive radiotherapy
Trial: 22983924
Drug: Topiramate (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (maximum dose of 75 mg)
Trial: 10754735
Drug: No thrombolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No thrombolytic therapy
Trial: 9305335
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg/d
Trial: 9305335
Drug: Gabapentin 1200
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 1200 mg/d
Trial: 17568397
Drug: Cocaine (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (0, 12, 25, and 50 mg)
Trial: 15036550
Drug: Gabapentin (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (0 mg/d)
Trial: 11751775
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (CI) of ceftazidime 1 g iv followed by a 4.5 g CI over 24 h
Trial: 11751775
Drug: 8-hourly administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8-hourly administration of ceftazidime 1.5 g tds
Trial: 363333
Drug: Metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 100 mg twice daily + Chlorthalidone 50 mg daily
Trial: 31120272
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment (NT) control
Trial: 28031021
Drug: Usual physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual physical therapy
Trial: 19593175
Drug: OFC (olanzapine/fluoxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OFC (olanzapine/fluoxetine combination)
Trial: 15261700
Drug: Second treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second treatments (real or sham)
Trial: 16181532
Drug: Astragalus injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astragalus injection (AI)
Trial: 9204358
Drug: Iopentol (Imagopaque
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopentol (Imagopaque 350 mg I/ml)
Trial: 9204358
Drug: Diatrizoate (Urografin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diatrizoate (Urografin 370 mg I/ml)
Trial: 2927976
Drug: Bennett‐Twin nebulizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bennett‐Twin nebulizer (output 0.31 ml/min, nebulization time 1 min)
Trial: 2927976
Drug: Wright nebulizer
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wright nebulizer (output 0.15 ml/min, nebulization time 2 min)
Trial: 2927976
Drug: Wright nebulizer
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wright nebulizer driven by a flow rate of 12 L/min (output 0.30 ml/min, nebulization time 1 min)
Trial: 31885071
Drug: RBC transfusion
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC transfusion at a Hb threshold of 7 g/dl
Trial: 31885071
Drug: RBC transfusion
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC transfusion at a Hb threshold of 9 g/dl
Trial: 28264612
Drug: Ingenol disoxate
RxNorm normalized name: Ingenol disoxate
DrugBank: Ingenol disoxate (DB15109)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingenol disoxate 0.018% gel
Trial: 21806518
Drug: Integrated cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated cognitive behaviour therapy and motivational interviewing (CBT/MI) delivered by a therapist
Trial: 21806518
Drug: Person-centred therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Person-centred therapy (PCT) - control group
Trial: 19329193
Drug: Daytime intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daytime intravenous glucocorticoid treatment
Trial: 19329193
Drug: Nighttime intravenous
RxNorm normalized name: Flonase Nighttime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nighttime intravenous glucocorticoid treatment
Trial: 2679269
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment protocols
Trial: 16886837
Drug: Sarpogrelate 200
RxNorm normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate 200 mg bid
Trial: 16886837
Drug: Sarpogrelate 200
RxNorm normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate 200 mg tid
Trial: 15236142
Drug: Nebulized adrenaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized adrenaline (3 mg)
Trial: 8422235
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs or a current of reverse polarity applied
Trial: 8422235
Drug: Electric currents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electric currents (3.5-5.0 mA) applied for 20 min to 10 solutions in cadaveric bladders
Trial: 2878678
Drug: Bufuralol 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bufuralol 7.5 mg
Trial: 2878678
Drug: Bufuralol 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bufuralol 60 mg
Trial: 2878678
Drug: Bufuralol 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bufuralol 120 mg
Trial: 26404425
Drug: Spray cryotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray cryotherapy
Trial: 20329382
Drug: Standard MDT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard MDT + once a month supervised 100 mg of Minocycline and 400 mg of Ofloxacin for 12 months
Trial: 12973820
Drug: Modified-release methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified-release methylphenidate (Ritalin LA) 40 mg administered intact with a high-fat breakfast
Trial: 12973820
Drug: Modified-release methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified-release methylphenidate (Ritalin LA) 40 mg sprinkled on applesauce
Trial: 11885169
Drug: Hydroxyapatite (HA)‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyapatite (HA)‐coated implants
Trial: 11885169
Drug: Non‐coated implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non‐coated implants
Trial: 11885169
Drug: Non‐coated implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non‐coated implants in bone quality 3
Trial: 9003951
Drug: 5% oxatomide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% oxatomide gel
Trial: 9003951
Drug: Placebo (petrolatum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (petrolatum ointment)
Trial: 1510262
Drug: Physiologic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiologic saline solution (placebo group)
Trial: 6239548
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia applied to the fallopian tubes
Trial: 1422291
Drug: No topical
RxNorm normalized name: Altreno Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No topical anesthesia
Trial: 25833784
Drug: Mamba (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mamba (50 g, 260 kcal, >75% of RDA for critical micronutrients)
Trial: 25833784
Drug: Tablet Yo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet Yo (42 g, 165 kcal)
Trial: 17408017
Drug: Ketoconazole (KTZ)
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole (KTZ) at a 600 mg/day maintenance dose for periods ranging from 15 days to 13 years.
Trial: 7517829
Drug: Intensive drug
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive drug treatment (combinations of colestipol, nicotinic acid and lovastatin)
Trial: 7517829
Drug: Diet and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet and modest doses of colestipol (Control)
Trial: 7517829
Drug: Diet and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet and lovastatin (up to 80 mg daily)
Trial: 7517829
Drug: Intensive drug
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive drug treatment (in women)
Trial: 3139326
Drug: Intravenous nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nitroglycerin (NG) therapy
Trial: 31777235
Drug: 10-time electroacupuncture
RxNorm normalized name: Return 10 TIME LOCK PROGRAM KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-time electroacupuncture treatment (once a day for 10 times)
Trial: 31777235
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between 5-time and 10-time treatment groups
Trial: 28502496
Drug: SC401 (1530
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC401 (1530 mg omega-3 fatty acids EE) under fasted conditions
Trial: 28502496
Drug: SC401 (1530
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC401 (1530 mg omega-3 fatty acids EE) under low-fat meal conditions
Trial: 28502496
Drug: SC401 (1530
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC401 (1530 mg omega-3 fatty acids EE) under high-fat meal conditions
Trial: 28502496
Drug: SC401 (1530
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC401 (1530 mg omega-3 fatty acids EE) under low-fat/high-fat meal conditions
Trial: 14644393
Drug: Rosuvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (40 mg/day for 8 weeks)
Trial: 10770982
Drug: Pegvisomant 10
RxNorm normalized name: pegvisomant 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegvisomant 10 mg
Trial: 10770982
Drug: Pegvisomant 15
RxNorm normalized name: pegvisomant 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegvisomant 15 mg
Trial: 10770982
Drug: Pegvisomant 20
RxNorm normalized name: pegvisomant 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegvisomant 20 mg
Trial: 9384476
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy and autologous stem cell transplantation
Trial: 9384476
Drug: Conventional-dose salvage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-dose salvage therapy prior to high-dose therapy
Trial: 9796516
Drug: Combination inferior
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination inferior alveolar nerve block plus incisive nerve block
Trial: 4010949
Drug: Levamisole 150
RxNorm normalized name: levamisole 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole 150 mg
Trial: 31348349
Drug: Hand therapy
RxNorm normalized name: Octinoxate 3.00 mL in 75 mL / Avobenzone 1.5 mL in 75 mL TOPICAL CREAM [Botanics Daily Hand Therapy Sunscreen SPF 10]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand therapy (supervised sessions and home exercises); mean 9.2 sessions over 14.2 weeks
Trial: 28760939
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (<140 mmHg)
Trial: 27983572
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 µg daily for six weeks)
Trial: 19570717
Drug: Tonabersat 40
RxNorm normalized name: Tonabersat
DrugBank: Tonabersat (DB06578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tonabersat 40 mg once daily
Trial: 8608684
Drug: Aceclofenac (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aceclofenac (100 mg twice daily)
Trial: 22462425
Drug: Diclofenac (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (75 mg twice daily)